Adjuvant topical dorzolamide or timolol with intravitreal bevacizumab for diabetic macular edema: A double-blind randomized controlled trial. (2024). Journal of Current Biomedical Reports, 5(1), 14-19. https://doi.org/10.61882/jcbior.5.1.279